Investor Relations (English)
ITGI Medical Ltd (Interventional Technologies for Graft Implantations ( TASE: ITGI ) is a bio-medical engineering company specializing in the research and development, design, manufacture and distribution of high quality heterologous tissue covered stents for cardiology, neurological and peripheral Interventions and niche bail out products for vascular applications. We have proposed to provide the medical community with “the best service for the best product” to accomplish our philosophy of “Help people heal people”.
ITGI Medical – In a nut shell
- Specializes in Heterologous tissue covered stents for unique applications in various blood vessels.
- The Company develops Heterologous Tissue Covered Stents for indications where other solutions are not ideal.
- The Over & Under® stent which is manufactured by the Company is being used to solve issues in coronary arteries mainly in degenerated Saphneous Vein Grafts, aneurisms and arterial perforations.
- The Aneugraft™ stent family developed by the company is being developed to treat issues in brain blood vessels.
- Significant market potential of USD 1 Billion a year with anticipated growth of 50% until 2010*
- The first product achieved a CE Mark Certification
- Distribution agreements with channels in several countries
- Strong and broad intellectual property protected by patents.
- First commercial product designated to treat coronary blood vessels. Additional products under development.
- Target markets with no effective solutions (Coronary and Neuro)
- Reality and Vision - Side by side.
- The Over & Under® Stent was successfully tested in human and got CE Mark
- Serial manufacturing started and distribution channel is growing
- The Aneugraft™ stent for brain aneurisms treatment is a breakthrough!
* reference:
- US Market Opportunities in the Interventional Coronary revasculization Health Research International, April 2002.
- Covered Stents by Autologous Vascular Grafts: Effect of Radiation and External Heating of Stents, Journal of Invasive Cardiology.
- TASE
- News
- Events